Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05328947 · ClinicalTrials.gov registry record · NA
Normative Biomechanical Measures of Reaching in Able-Bodied Adults
A NA study of Individuals With Functional Limitations Which May Impact Their Forward Reach, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05328947: Completed NA study of Individuals With Functional Limitations Which May Impact Their Forward Reach, sponsored by Mayo Clinic.
NCT05328947 is a NA study of Individuals With Functional Limitations Which May Impact Their Forward Reach that has completed, run by Mayo Clinic. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05328947, a NA study of Individuals With Functional Limitations Which May Impact Their Forward Reach, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
A study to obtain normative values and repeatability measures during functional reaching tasks in able-bodied individuals with no functional limitations.
Primary Outcome
Change in measurements of joint angles at the shoulders, hips, knees, and ankles, measured in degrees.
Conditions Studied
Interventions
- OTHER Modified Functional Reach and Functional Reach
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-07-14 |
| Est. Completion | 2023-06-29 |
| Phase | NA |
What the finished NCT05328947 record still lists
NCT05328947 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Individuals With Functional Limitations Which May Impact Their Forward Reach appearing as the primary indexed condition, and to 1 intervention - of which Modified Functional Reach and Functional Reach is the first listed.
NCT05328947 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05328947 about?
NCT05328947 is a clinical study titled "Normative Biomechanical Measures of Reaching in Able-Bodied Adults". A study to obtain normative values and repeatability measures during functional reaching tasks in able-bodied individuals with no functional limitations.
What is the current status of trial NCT05328947?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-07-14. Estimated completion is 2023-06-29.
What conditions does trial NCT05328947 study?
This clinical trial studies the following conditions: Individuals With Functional Limitations Which May Impact Their Forward Reach.
What interventions are being tested in trial NCT05328947?
The interventions under investigation include: Modified Functional Reach and Functional Reach (OTHER).
Who is sponsoring clinical trial NCT05328947?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05328947 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05328947's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI